News About: R&D
SK Chemicals will jointly carry out development and Phase 3 clinical trial of next generation children enteritis vaccine
SK Chemicals is enlarging its position in the international market with its technology and manufacturing power in vaccine.
SK Chemicals announced on the 1st that it signed an agreement for development of a next-gener...
Korea conducts 2nd largest number of clinical trials for stem cell treatments in the world
It was observed Korea became a country that conducted the 2nd highest number of clinical trials for stem cell treatments after the U.S.
The Ministry of Food and Drug Safety’s National Institute of Food and Drug Safet...
Oscotec’s FDA-approved clinical trials for treatment of acute myeloid leukemia
Oscotec(CEO Jung-Geun Kim), a new drug development company, announced on the 13th that it made an agreement since the U.S. Phase 1 clinical trial project of the next-generation new drug candidate(SKI-G-801) for the tr...
What will be the answers for future new drug development?
What will be the answers for future new drug development?
Celgene chose ‘innovation followed by continuous efforts on new drug development’ and ‘active cooperation with various partners.’
In the lecture about ‘Chang...
Korea advanced in global clinical trials, showing 3.41% market share last year
The number of clinical trials is decreasing, but the Korean clinical trial’s market share in the global market was actually increased by approx. 10% to 3.42%. There were changes in ranking as well because of the China...
R&D chiefs from Korean and overseas pharmas will illustrate present and future of ‘open innovation’
The Korea’s largest ‘Open Innovation’ stage will open for the pharmaceutical industry.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won) and the Korean Research-based Pharmaceuti...
Bloody competition among bioequivalence test service organizations causes shutdown of business
Due to fierce competition among service organizations for bioequivalence test, one of them decided to shut down business.
Korea Pharmaceutical Test & Research Institute, an agency of the Korea Pharmaceutical Traders ...
Pharmas hesitated in developing generics, showing decrease in bioequivalently-tested drugs
It was observed there were only 96 pharmaceutical products approved through bioequivalence test this year. This is because pharmaceutical companies are hesitated in developing generic products.
According to the Minis...
Development of generics focusing on metabolism, cardiovascular system and central nervous system
The National Institute of Food and Drug Safety Evaluation(NIFDS) at Ministry of Food and Drug Safety announced the number of generic products approved was similar to the last year even though the number of approvals o...
Pharmas continue this R&D this year too
New drug development will continue.
Major Korean pharmaceutical companies have a plan to export new drug pipelines and commercialize them. In order to export, transfer and commercialize technology, they have more act...
